Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 2, 2023 3:42 PM 2 min read

E.L.F. Beauty Will Repeat The Growth Playbook With Naturium Acquisition, Says Analyst

by Shivani Kumaresan Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

DA Davidson analyst Linda Bolton Weiser raised the price target on Buy-rated E.L.F. Beauty, Inc. (NYSE:ELF) from $176 to $178.

ELF's fiscal second-quarter revenue increased 76% year-over-year to $215.5 million, beating the estimate. The company reported earnings of 82 cents per share, which beat estimates of 51 cents per share.

Operating profit was +123% to $56.6 million, exceeding consensus of $38.8 million, analyst notes.

ELF has entered Douglas in Italy with great success, and more new country entries in the coming quarters are expected, as the company has built a team of more than 30 people in the U.K. to drive international expansion, writes the analyst.

ELF is rebuilding its inventory in FY24 to better meet demand, says the analyst.

ELF closed on its acquisition of Naturium for $355 million, consisting of cash and $72 million of ELF stock. After the acquisition, skincare represents about 18% of sales versus about 9% previously, notes the analyst.

The analyst writes that ELF's color cosmetics consumption in tracked channels increased 51% in Q2 FY24, far outpacing category growth of +3%.

ELF's skincare consumption in tracked channels was +129% Y/Y in the quarter, outpacing category growth of +10%. The company is ranked number 14 in mass skincare versus 19 a year ago, with its market share gaining 80 basis points to 1.6%.

Gross margin was 70.7% versus 65.0% in F2Q23 (consensus was 67.9%), due to FX, favorable mix, cost savings, lower inventory adjustments, and lower transportation costs, writes the analyst.

The analyst raised Q3 FY24 organic sales estimates to 35% from 24% previously and Q4 FY24 organic sales estimate to 21% from 10%.

Price Action: ELF shares are trading higher by 2.97% at $97.35 on the last check Thursday.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEquitiesNewsPrice TargetReiterationMarketsAnalyst RatingsTrading IdeasGeneralBriefsExpert Ideas
ELF Logo
ELFe.l.f. Beauty Inc
$72.960.52%
Overview

Meanwhile, the analyst lowered the 2HFY24 EBITDA estimate to $66 million from $75 million to reflect higher marketing spending, in order to get to an EBITDA estimate in line with the high end of the guidance range.

ELF Logo
ELFe.l.f. Beauty Inc
$72.960.52%
Overview
Comments
Loading...